dawn-mockup-2x
UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
30. September 2024 09:48 ET | ResMed Inc.
ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
ATN30i Female Fitting 3 (1)
UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
30. September 2024 09:23 ET | ResMed Inc.
ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
ATN30i Female Fitting 3 (1)
ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
30. September 2024 08:10 ET | ResMed Inc.
ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
dawn-mockup-2x
ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
30. September 2024 08:01 ET | ResMed Inc.
ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
ResMed logo-fullcolor.jpg
Vaping Expected to Increase COPD Health and Economic Burden by 2050
10. September 2024 08:00 ET | ResMed Inc.
Vaping Expected to Increase COPD Health and Economic Burden by 2050 New ResMed-supported research presented at ERS 2024
External Nasal Dilator Market to Reach $162.4 Million, Globally, by 2033 at 5.1% CAGR: Allied Market Research
16. August 2024 10:14 ET | Allied Analytics LLP
Wilmington, Delaware, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "External Nasal Dilator Market by Application (Snoring, Sleep apnea, Nasal congestion and...
ResMed logo-fullcolor.jpg
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia
10. Juni 2024 09:05 ET | ResMed Inc.
ResMed-supported research presented at SLEEP2024 demonstrates the effectiveness and value of positive airway pressure (PAP) treatment for OSA.
Apnimed.png
Apnimed Announces a Robust Slate of Presentations at SLEEP 2024, Including an Analysis of the Prevalence of Obesity in Obstructive Sleep Apnea
23. Mai 2024 09:50 ET | Apnimed, Inc.
Apnimed Announces a Robust Slate of Presentations at SLEEP 2024, Including an Analysis of the Prevalence of Obesity in Obstructive Sleep Apnea
PRO3-420-A ProSomnus, Inc Logo_horizontal.png
ProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual Meeting
13. Mai 2024 09:00 ET | ProSomnus Sleep Technologies, Inc.
ProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual Meeting
PRO3-420-A ProSomnus, Inc Logo_horizontal.png
Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices
09. Mai 2024 18:30 ET | ProSomnus Sleep Technologies, Inc.
Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices